Last reviewed · How we verify

Tramadol Hydrochloride 100 MG

Assiut University · FDA-approved active Small molecule Quality 5/100

Tramadol Hydrochloride 100 MG is a Small molecule drug developed by Assiut University. It is currently FDA-approved. Also known as: tamol, Mandolgin Retard (100 mg), TRAMAL, group C.

At a glance

Generic nameTramadol Hydrochloride 100 MG
Also known astamol, Mandolgin Retard (100 mg), TRAMAL, group C, Tramadol
SponsorAssiut University
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Tramadol Hydrochloride 100 MG

What is Tramadol Hydrochloride 100 MG?

Tramadol Hydrochloride 100 MG is a Small molecule drug developed by Assiut University.

Who makes Tramadol Hydrochloride 100 MG?

Tramadol Hydrochloride 100 MG is developed and marketed by Assiut University (see full Assiut University pipeline at /company/assiut-university).

Is Tramadol Hydrochloride 100 MG also known as anything else?

Tramadol Hydrochloride 100 MG is also known as tamol, Mandolgin Retard (100 mg), TRAMAL, group C, Tramadol.

What development phase is Tramadol Hydrochloride 100 MG in?

Tramadol Hydrochloride 100 MG is FDA-approved (marketed).

Related